A socially oriented non-financial development institution and a major organizer of international conventions; exhibitions; and business, public, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.

The Roscongress Foundation is a socially oriented non-financial development institution and a major organizer of international conventions; exhibitions; and business, public, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 132 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 70 countries worldwide.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Providing Medications to the Russian Population
26 May 2018
08:30—09:45

Increasing availability of high-quality medications, especially in outpatient settings should become a priority for the development of healthcare in the Russian Federation for the coming years. This would alleviate illness complications and decrease the use of more expensive types of medical assistance, as well as ease the financial burden on families. Today, only a limited number of individuals have access to medications in outpatient settings in Russia, with this expenditure (both budgetary and individual) representing 17% of the total spending on medications. In the EU countries this figure is three-fold larger with state co-financing at least 50%. Addressing this issue will help patients and provide a powerful, targeted stimulus for the development of the pharmaceutical industry and science in Russia. How important is it to increase the volume of free medicines provided in outpatient settings, and what share of the cost should be borne by individuals? Should the structure of the pharmaceutical consumption in Russia undergo changes? Which medicines are vital to ensure that the quality of care in Russia meets international standards? What legal barriers must be removed to increase the efficiency of state procurement of medicines — from the perspective of manufacturers, distributors and consumers (state and medical organizations)? Can players in the pharmaceutical market propose breakthrough solutions for providing medications to the Russian population?

Date
26.05.2018
Forum
SPIEF
Started at
08:30—09:45
Conference hall
Congress Centre, Business Breakfast Hall 2
Analytics on the topic